The partnership will combine OpenBench’s discovery platform with Concept Life Sciences’ expertise in medicinal chemistry.
OpenBench employs its structure-based AI to virtually screen trillions of compounds. Credit: Gorodenkoff / Shutterstock.com.
Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech companies.
The collaboration aims to accelerate hit identification for these companies through a fee-for-success approach. Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
